Lite Strategy, Inc.
LITS Nasdaq Pharmaceutical Preparations Financials FY2017โFY2026
Last close ยท Oct 23, 2026
$1.16
2.5%What Lite Strategy, Inc. does
No business description yet.
- Legal name
- Lite Strategy, Inc.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K ยท Sep 28, 2026
- Accession ยท CIK
- 0001193125-26-405328
0001262104
Revenue and margins
Lite Strategy, Inc. had โ of revenue in fiscal 2026.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was โ in fiscal 2026, โ of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Lite Strategy, Inc. returned $4.9M to shareholders in fiscal 2026. The diluted share count rose 418.7%.
Balance sheet
Cash, debt and the ratios that show how comfortably Lite Strategy, Inc. can carry it.
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $153M | $101M | $38.3M | $18.0M | $5.7M |
| Current ratio | 6.8x | 5.3x | 4.9x | 13.5x | 5.7x |
| Quick ratio | 6.8x | 5.3x | 4.9x | 13.5x | 5.7x |
| Total assets | $178M | $121M | $41.4M | $18.3M | $42.7M |
| Total liabilities | $125M | $96.2M | $8.4M | $1.4M | $1.1M |
| Shareholders' equity | $52.4M | $24.6M | $33.0M | $16.9M | $41.6M |
| Net debt (โ = net cash) | โ | โ | โ | โ | โ |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. โPlanโ marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
โ
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8โ9 is strong, 0โ2 weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations is positive | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Return on assets rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Cash from operations exceeds net income | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Debt fell relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Current ratio rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Share count didn't rise | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Gross margin rose | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| Revenue rose relative to assets | โ | โ | โ | โ | โ | โ | โ | โ | โ | โ |
| F-score | โ / 3 | 2 / 8 | 3 / 8 | 5 / 8 | 3 / 8 | 4 / 8 | 2 / 7 | 4 / 7 | 2 / 7 | โ / 6 |
| Accruals ratio | โ1.5% | โ23.7% | 13.5% | โ55.7% | โ4.7% | โ3.0% | 13.7% | 84.4% | 16.4% | โ203.5% |
| Altman Z'' | 7.00 | โ1.49 | โ6.04 | 1.56 | โ2.45 | โ4.01 | โ8.00 | โ18.94 | โ59.27 | โ5.11 |
10 years of figures
Amounts in USD. Hover a ratioโs name for its definition.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $23.2M | $1.6M | $4.9M | $27.8M | $34.8M | $40.7M | $48.8M | $65.3M | $0.0M | โ |
| Gross profit | $18.2M | โ$1.8M | $0.7M | $25.1M | $33.4M | $40.7M | โ | โ | โ | โ |
| Research and development | $7.2M | $17.0M | $32.3M | $34.1M | $69.4M | $85.6M | $52.5M | $16.6M | $3.9M | $0.1M |
| Operating income | $2.4M | โ$28.6M | โ$46.2M | โ$25.7M | โ$60.4M | โ$75.5M | โ$36.8M | $14.5M | โ$17.5M | โ$66.6M |
| Pretax income | $2.7M | โ$40.1M | โ$16.8M | โ$47.2M | โ$41.3M | โ$54.5M | โ$31.8M | $17.8M | โ$15.9M | โ$71.2M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | $2.7M | โ$40.1M | โ$16.8M | โ$47.2M | โ$41.0M | โ$54.0M | โ$32.0M | $18.0M | โ$15.9M | โ$71.2M |
| Net income to common | $2.7M | โ$40.1M | โ$16.8M | โ$47.2M | โ$41.3M | โ$54.5M | โ$31.8M | โ | โ | โ |
| Diluted EPS | $0.07 | โ$0.97 | โ$0.75 | โ$0.52 | โ$0.60 | โ$9.99 | โ$4.78 | $2.67 | โ$2.39 | โ$2.06 |
| Diluted shares | 0.04B | 0.04B | 0.07B | 0.09B | 0.11B | 0.01B | 0.01B | 0.01B | 0.01B | 0.03B |
| Cash flow | ||||||||||
| Cash from operations | $3.5M | โ$21.0M | โ$29.4M | $34.3M | โ$32.0M | โ$48.7M | โ$52.5M | โ$50.5M | โ$20.8M | โ$9.1M |
| Capital expenditure | $0.1M | โ | $0.2M | $0.9M | $0.7M | $0.5M | $0.0M | $0.0M | $0.0M | โ |
| Free cash flow | $3.4M | โ | โ$29.6M | $33.4M | โ$32.7M | โ$49.2M | โ$52.5M | โ$50.5M | โ$20.8M | โ |
| Depreciation and amortization | $0.1M | $0.1M | $0.1M | $0.1M | $0.3M | $0.3M | $0.4M | $0.4M | $0.4M | $0.0M |
| Stock-based compensation | $2.3M | $3.2M | $6.6M | $6.8M | $10.2M | $8.4M | $3.6M | $2.3M | โ$0.1M | $1.3M |
| Share buybacks | โ | โ | โ | โ | โ | โ | โ | โ | $0.0M | $4.9M |
| Dividends paid | โ | โ | โ | โ | โ | โ | $0.0M | $11.7M | $0.0M | โ |
| Dividends and buybacks | โ | โ | โ | โ | โ | โ | $0.0M | $11.7M | $0.0M | $4.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $53.6M | $103M | $74.5M | $183M | $153M | $153M | $101M | $38.3M | $18.0M | $5.7M |
| Current assets | $55.3M | $104M | $82.2M | $209M | $165M | $167M | $108M | $40.8M | $18.3M | $6.1M |
| Current liabilities | $4.9M | $7.9M | $14.3M | $13.8M | $20.2M | $24.4M | $20.3M | $8.4M | $1.4M | $1.1M |
| Property and equipment, net | $0.1M | $0.0M | $0.2M | $1.1M | $1.5M | $1.7M | $1.3M | $0.4M | $0.0M | โ |
| Intangible assets | $0.3M | $0.3M | $0.3M | โ | โ | โ | โ | โ | โ | โ |
| Total assets | $55.7M | $105M | $82.7M | $210M | $174M | $178M | $121M | $41.4M | $18.3M | $42.7M |
| Total liabilities | $4.9M | $54.2M | $34.7M | $133M | $125M | $125M | $96.2M | $8.4M | $1.4M | $1.1M |
| Preferred stock | โ | โ | โ | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $50.8M | $50.5M | $47.9M | $77.1M | $49.5M | $52.4M | $24.6M | $33.0M | $16.9M | $41.6M |
| Margins | ||||||||||
| Gross margin | 78.5% | โ108.6% | 13.3% | 90.4% | 96.0% | 100.0% | โ | โ | โ | โ |
| Operating margin | 10.3% | โ1,762.4% | โ940.9% | โ92.6% | โ173.7% | โ185.5% | โ75.3% | 22.3% | โ | โ |
| EBITDA margin | 10.6% | โ1,759.1% | โ939.3% | โ92.2% | โ172.8% | โ184.7% | โ74.5% | 22.9% | โ | โ |
| Net margin | 11.5% | โ2,470.3% | โ342.2% | โ170.0% | โ117.8% | โ132.7% | โ65.6% | 27.6% | โ | โ |
| FCF margin | 14.8% | โ | โ603.1% | 120.2% | โ93.9% | โ121.0% | โ107.6% | โ77.3% | โ | โ |
| Returns | ||||||||||
| Return on capital employed | 4.7% | โ29.5% | โ67.6% | โ13.1% | โ39.3% | โ49.2% | โ36.6% | 44.0% | โ103.1% | โ160.0% |
| Return on equity | 5.3% | โ79.1% | โ34.2% | โ75.5% | โ64.8% | โ106.0% | โ83.1% | 62.5% | โ63.8% | โ243.0% |
| Return on assets | 4.8% | โ50.0% | โ18.0% | โ32.3% | โ21.4% | โ30.7% | โ21.4% | 22.2% | โ53.5% | โ233.4% |
| Return on tangible equity | 5.3% | โ79.9% | โ35.3% | โ61.2% | โ83.5% | โ103.9% | โ129.3% | 54.5% | โ94.2% | โ170.9% |
| Growth | ||||||||||
| Revenue growth | โ | โ93.0% | 203.0% | 464.7% | 25.4% | 17.0% | 19.9% | 33.8% | โ100.0% | โ |
| Net income growth | โ | โ1,600.7% | โ | โ | โ | โ | โ | โ | โ188.6% | โ |
| EPS growth | โ | โ1,485.7% | โ | โ | โ | โ | โ | โ | โ189.5% | โ |
| FCF growth | โ | โ | โ | โ | โ197.9% | โ | โ | โ | โ | โ |
| Share count change | โ | 12.2% | 74.7% | 25.8% | 25.7% | โ94.5% | 6.5% | 0.0% | 0.0% | 418.7% |
| Financial health | ||||||||||
| Current ratio | 11.4x | 13.2x | 5.7x | 15.2x | 8.2x | 6.8x | 5.3x | 4.9x | 13.5x | 5.7x |
| Quick ratio | 11.4x | 13.2x | 5.7x | 15.2x | 8.2x | 6.8x | 5.3x | 4.9x | 13.5x | 5.7x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.2% | โ | 4.4% | 3.2% | 2.0% | 1.2% | 0.1% | 0.0% | โ | โ |
| Stock comp / revenue | 9.9% | 198.3% | 133.5% | 24.5% | 29.4% | 20.5% | 7.4% | 3.5% | โ | โ |
| Quality scores | ||||||||||
| Piotroski F-score | โ | 2.0 | 3.0 | 5.0 | 3.0 | 4.0 | 2.0 | 4.0 | 2.0 | โ |
| Altman Z'' | 7.0 | โ1.5 | โ6.0 | 1.6 | โ2.5 | โ4.0 | โ8.0 | โ18.9 | โ59.3 | โ5.1 |
| Accruals ratio | โ1.5% | โ23.7% | 13.5% | โ55.7% | โ4.7% | โ3.0% | 13.7% | 84.4% | 16.4% | โ203.5% |
Source: SEC EDGAR XBRL filings (CIK 0001262104). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only โ not investment advice. Check the original filings before relying on any figure.
